Viridian Therapeutics, Inc. (VRDN)
28.10
-0.25
(-0.88%)
USD |
NASDAQ |
Mar 26, 09:58
Viridian Therapeutics Free Cash Flow : -277.36M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -12.01M |
| Plus Therapeutics, Inc. | -20.84M |
| Nutriband, Inc. | -5.647M |
| Immunovant, Inc. | -423.09M |
| Definium Therapeutics, Inc. | -131.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.23M |
| Cash from Investing (Quarterly) | -339.42M |
| Cash from Financing (Quarterly) | 406.39M |
| Free Cash Flow Per Share (Quarterly) | -0.2593 |
| Free Cash Flow to Equity (Quarterly) | -51.34M |
| Free Cash Flow to Firm (Quarterly) | -21.19M |
| Free Cash Flow Yield | -11.64% |